Meetings Keynote Address


Keynote Address

METABOLIC REPROGRAMMING AS A KEY DRIVER OF INFLAMMATION AND INNATE IMMUNITY
Sunday, June 9, 11:30 am - 12:30 pm



Dr. Luke O’Neill, PhD, FRS
Professor
Trinity College Dublin
School of Biochemistry and Immunology


Professor Luke O’Neill holds the Chair of Biochemistry at Trinity College Dublin where he leads the Inflammation Research Group.  He has a PhD in Pharmacology from the University of London and carried out Post-Doctoral research at Cambridge U.K. His research is in the area of the molecular basis to inflammation with a particular focus on innate immunity, Toll-like receptors, inflammasomes and metabolic reprogramming in macrophage activation. In 2016 he was named by Clarivates/Thompson Reuters as one of the world’s most influential scientists, being in the top 1% in Immunology. He is co-founder of 3 Spin-out companies -  Opsona Therapeutics,  Inflazome and Sitryx, which are developing new treatments for inflammatory diseases.  He has won numerous awards for his research including the European Federation of Immunology Societies medal, the International Cytokine and Interferon Society Milstein Award, The Royal Dublin Society Boyle Medal for Scientific Excellence, The Royal Irish Academy Gold Medal for Life sciences. He was elected a Fellow of the Royal Society in 2016.

 

Phone: 301-634-7080 Fax: 301-634-7099     Copyright by Shock Society · Terms Of Use · Privacy Statement